California Nanotechnologies is trading at $0.29, down 5.44% in live trading; its October 27 Q2 FY2027 report is the clearest company-specific context for the move.
- Revenue rose 23%, but the company posted a US$359,148 net loss versus net income a year earlier.
- Gross margin fell to 51% from 62%, and diluted loss per share was US$0.02.
- No separate October 29 company announcement explaining the live move was found.